You are here

Newborn Infant Vision Test

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R42EY022545-02A1
Agency Tracking Number: R42EY022545
Amount: $1,056,419.00
Phase: Phase II
Program: STTR
Solicitation Topic Code: N
Solicitation Number: PA15-270
Timeline
Solicitation Year: 2015
Award Year: 2016
Award Start Date (Proposal Award Date): 2016-09-30
Award End Date (Contract End Date): 2019-08-31
Small Business Information
944 1ST ST, La Salle, IL, 61301-2538
DUNS: 193897295
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 EDWARD KOPIDLANSKY
 (847) 804-7500
 ed@precision-vision.com
Business Contact
 EDWARD KOPIDLANSKY
Phone: (815) 223-2022
Email: lisa@precision-vision.com
Research Institution
 OHIO STATE UNIVERSITY
 1960 Kenny Road
Columbus, OH, 43210-1016
 Nonprofit college or university
Abstract
Project Summary! This STTR Phase II project continues the development of the Newborn Acuity Cardstm and the Newborn Contrast Cardstm Together these Newborn Cards form a new clinical test of visual acuity and contrast sensi tivity for use on newborn full term and preterm infants The stimuli are square wave gratings which the examiner presents to the infant in a fixation and following protocol and determines from the infantandapos s looking behavior whether he she saw each stimulus or not An infantandapos s visual acuity or contrast sensitivity is the highest spatial frequency or lowest contrast the least visible stimulus he she can see The proposed Phase II work will include a training study in which the best method for training examiners in the use of the cards will be established and documented The project will also establish age norms by meas uring visual acuity and contrast sensitivity on a large sample of healthy full term and preterm infants Because the test is so new it is not known how reliable the measurements are Therefore this project will include re peated testing of individual newborn infants on different days by different examiners The Intraclass Correla tion Coefficient will determine whether measurement of an infantandapos s level of visual function produces results that are more related to the infantandapos s vision rather than to the more ephemeral characteristics of the infantandapos s alertness or the skill of the examiner The clinical utility of the test its sensitivity and specificity in detecting vision disor ders has not been established so this project will explore these parameters by testing a sample of infants with and without Retinopathy of Prematurity ROP ROP is not the only serious visual disorder experienced by newborn infants but it is one of the most prevalent and most serious This is not a clinical trial but the results on infants with varying stages of ROP will be a good indicator of whether the Newborn Acuity Cards and Newborn Contrast Cards are sensitive and specific indicators of healthy visual function The results on the ROP infants will also be used in conjunction with the age norms to establish a normal cutoff value for a screening test of only a few cards which will further increase the convenience of this noninvasive test The Newborn Contrast Cards and Newborn Acuity Cards will allow the physician to monitor the vision of patients in the Neonatal Intensive Care Unit and other pediatric settings in cases where the visual disorder is progressing as in Retinopathy of Prematurity or Cortical Vision Impairment or where the disorder may be treated Its potential market includes hospitals neonatologists pediatricians and pediatric ophthalmologists around the world In of cases of childhood blindness in the U S the blinding disorder is present in the neonatal period and the inability to see well may be the only sign of a blinding disorder in half of those cases Ultimately we want every newborn infantandapos s vision to be screened and every premature infantandapos s vision to be tested more thoroughly and this project will be the next step towards making this plan a reality Project Narrative This project will continue the development a clinical test of visual acuity and contrast sensitivity for use with newborn and premature infants in the Neonatal Intensive Care unit and other pediatric settings In of cases of childhood blindness and visual impairment in the U S the blinding disorder is present in the neonatal period and the inability to see well is the only sign of the disorder in about half of those cases Here we investigate the repeatability of the test age norms for gestational ages weeks and the clinical utility of the test in cases of Retinopathy of Prematurity

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government